Role of Hydrogen Sulfide in Systemic and Pulmonary Hypertension: Cellular Mechanisms and Therapeutic Implications | BenthamScience

Role of Hydrogen Sulfide in Systemic and Pulmonary Hypertension: Cellular Mechanisms and Therapeutic Implications

Author(s): Joshua Brampton, Philip I. Aaronson.

Journal Name: Cardiovascular & Hematological Agents in Medicinal Chemistry

Volume 14 , Issue 1 , 2016

Abstract:

There is increasing interest in the possible therapeutic benefits of the gasotransmitter hydrogen sulfide (H2S; sulfide), and drugs which release sulfide are currently being evaluated in both preclinical and clinical studies as treatments for conditions ranging from cancer to cardiovascular disease to inflammation. Sulfide is generally considered to act as a vasodilator, and it is therefore not surprising that the effects of sulfide donors on both systemic and pulmonary hypertension are being examined. In this review, we provide a critical evaluation of both the evidence that H2S may be of benefit in treating systemic and pulmonary hypertension, and of current hypotheses regarding the cellular mechanisms underlying sulfide’s effects on the systemic and pulmonary vascular systems.

Keywords: Cystathionine γ lyase, endothelium derived hyperpolarization, hydrogen sulfide, hypertension, nitric oxide, pulmonary hypertension, sulfhydration.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 14
ISSUE: 1
Year: 2016
Page: [4 - 22]
Pages: 19
DOI: 10.2174/1871525714999160201121220
Price: $58

Article Metrics

PDF: 45